Ming-Ji Jin Selected Research

Neoplasms (Cancer)

1/2021	Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
3/2019	Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on their Cell Cycle Arrest, Apoptosis Pathway and Migration.
1/2019	Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
3/2017	Inhibiting the proliferation, migration and invasion of triple negative breast cancer cells through anti-tumor human serum albumin nanoparticles loading aziditaxel as a novel taxane derivative.
1/2016	Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI.
1/2016	Lx2-32c-loaded polymeric micelles with small size for intravenous drug delivery and their inhibitory effect on tumor growth and metastasis in clinically associated 4T1 murine breast cancer.
6/2014	Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
2/2014	Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.
8/2012	Preparation and characterization of polymeric nanoparticles for siRNA delivery to down-regulate the expressions of exogenous and endogenous target genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Ji Jin Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 08/2012
4	Breast Neoplasms (Breast Cancer) 03/2019 - 06/2014
2	Glioma (Gliomas) 12/2021 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2019 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2016
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 11/2018
1	Inflammation (Inflammations) 11/2018
1	Triple Negative Breast Neoplasms 03/2017
1	Polyploidy 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 02/2014

Drug/Important Bio-Agent (IBA)

3	MicellesIBA 01/2016 - 02/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 01/2021
2	Peptides (Polypeptides)IBA 12/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2012
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	Apolipoproteins E (ApoE)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	LDL Receptors (LDL Receptor)IBA 12/2021
1	Protein CoronaIBA 12/2021
1	Liposomes (Liposome)IBA 01/2021
1	CholesterolIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	LigandsIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Cytochromes c (Cytochrome c)IBA 03/2019
1	Amino Acids FDA Link 03/2019
1	Emodin (Archin)IBA 03/2019
1	Caspase 9IBA 03/2019
1	Caspase 3 (Caspase-3)IBA 03/2019
1	Purinergic P2X7 ReceptorsIBA 11/2018
1	LipidsIBA 11/2018
1	leucodinIBA 11/2018
1	Nanoparticle Drug Delivery SystemIBA 03/2017
1	Human Serum Albumin FDA LinkGeneric 03/2017
1	Lx2-32c compoundIBA 03/2017
1	taxaneIBA 03/2017
1	SurvivinIBA 01/2016
1	PolyethyleneimineIBA 01/2016
1	DisulfidesIBA 01/2016
1	LuciferasesIBA 01/2016
1	cremophor ELIBA 01/2016
1	SolutionsIBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014
1	Hormones (Hormone)IBA 02/2014
1	Docetaxel (Taxotere)FDA Link 02/2014
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2014

Therapy/Procedure

2	Therapeutics 12/2021 - 01/2021
1	Palliative Care (Palliative Therapy) 01/2019